Jeena Sikho Lifecare Ltd.

₹506.2

0.8 (0.1%)

JSLL Share Price

Pharmaceuticals & Biotechnology

As on September 9, 2026

SectorNA

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 6,292 Cr

P/E Ratio28.32

Dividend Yield0.45 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	509.23	Bearish
10-DMA	508.87	Bearish
20-DMA	510.78	Bearish
50-DMA	546.39	Bearish
100-DMA	593.66	Bearish
200-DMA	632.81	Bearish

Historical Performance

1 Year

-36.7%

3 Years

340.1%

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2023	Mar-2022
Net Sales	8,014	4,691	2,048	1,466
Total Expenditure	4,509	3,285	1,589	1,285
Other Income	85	67	26	15
Operating Profit	3,590	1,473	484	196
Interest	139	107	9	12
Depreciation	477	291	32	33
Profit Before Tax	2,974	1,076	443	151
Consolidated Net Profit	2,219	799	338	112
Adjusted EPS	18	6	3	1

Compounded Sales Growth

10 Years:40.5

5 Years:40.5

3 Years:31.4

TTM:11.3

Compounded Profit Growth

10 Years:81.6

5 Years:81.6

3 Years:45.7

TTM:22.6

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:63.9

TTM:-33.6

Return on Equity

10 Years:N/A

5 Years:N/A

3 Years:2.7

last year:17.8

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2023	Mar-2022
Share Capital	249	249	138	101
Total Reserves	4,394	2,306	1,120	264
Long-Term Borrowings	---	---	---	---
Total Non-Current Liabilities	920	834	2	12
Other Current Liabilities	729	459	139	119
Short Term Borrowings	---	100	---	64
Total Liabilities	6,640	4,131	1,506	615
Capital Work in Progress	21	112	11	50
Long Term Loans & Advances	100	79	122	64
Currents Investments	951	29	45	---
Short Term Loans and Advances	421	90	131	32
Total Current Assets	3,409	1,350	775	215
Total Assets	6,640	4,131	1,506	615
Adjusted Book Value	37	21	10	4

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 28.32, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 66.7%, indicating sustained price appreciation.
The stock carries a beta of 1.2, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹3590 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹8014 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 663694.8

No. of Shares: 1311 (Approx)

Performance:-33.6%

-336305.2

NIFTY Performance: -6.2%

1 day Top Gainers